Cannabinoids assay

For the quantitative in vitro determination of Cannabinoids in urine. This product is suitable for automated, semi-automated and manual use.

SKU: DA4010 Categories: , , , , , , , , Method: Homogeneous Enzyme Immunoassay Format: Liquid Size: R1 2x16.9ml, R2 2x8ml Assay Range: Refer to kit insert Working Stability: Stable up to the expiry date when stored at +2 to +8°C. Once opened, the reagent is stable on board the analyser for 28 days at approximately +10°C. Available Applications: RX daytona, RX daytona+, RX imola, RX monaco Tags: , , , , ,

$666.77

Out of stock

Description

Intended Use

For the quantitative in vitro determination of Cannabinoids in urine. This product is suitable for automated, semi-automated and manual use.

Clinical Significance

The principle, active constituent in marijuana (or hashish), obtained from Cannabis Sativa plant, is the
∆1-3,4-trans tetrahydrocannabinol, frequently referred to as ∆9-tetrahydocannabinol or ∆9-THC. It is one of the most commonly used illicit drugs in the United States. Marijuana is frequently self-administered for its mood-altering properties. Chronic use has been shown to cause reversible psychological impairment, an abstinence syndrome, and can cause users to develop tolerance. At low doses, it produces mixed depressant and stimulant effects; while at higher dose it acts as a CNS depressant.

∆9-THC is easily absorbed by inhalation (smoking) or ingestion through the gastrointestinal tract. Due to its highly fat-soluble nature ∆9-THC is readily deposited in fatty tissues, where it may remain for days or even weeks. It is primarily metabolised in the liver to a variety of compounds, the primary one being the (11-nor ∆9-THC-9-COOH). Approximately 70% of THC is excreted in faeces and urine within 72 hours of administration.

Available Applications

  • RX daytona
  • RX daytona+
  • RX imola
  • RX monaco

Product Availability

Product Availability

Product availability may vary from country to country